Barings’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,800
Closed -$1.01M 927
2018
Q1
$1.01M Buy
11,800
+6,200
+111% +$480K 0.01% 523
2017
Q4
$415K Hold
5,600
0.01% 764
2017
Q3
$323K Hold
5,600
0.01% 740
2017
Q2
$359K Sell
5,600
-5,600
-50% -$345K 0.01% 699
2017
Q1
$646K Buy
11,200
+5,600
+100% +$334K 0.01% 875
2016
Q4
$343K Hold
5,600
0.01% 737
2016
Q3
$387K Hold
5,600
0.01% 636
2016
Q2
$312K Hold
5,600
0.01% 772
2016
Q1
$340K Hold
5,600
0.01% 783
2015
Q4
$358K Hold
5,600
0.01% 734
2015
Q3
$375K Hold
5,600
0.01% 699
2015
Q2
$383K Hold
5,600
0.01% 756
2015
Q1
$311K Hold
5,600
0.01% 805
2014
Q4
$287K Hold
5,600
0.01% 802
2014
Q3
$206K Hold
5,600
﹤0.01% 906
2014
Q2
$219K Hold
5,600
0.01% 910
2014
Q1
$211K Hold
5,600
0.01% 879
2013
Q4
$212K Sell
5,600
-4,600
-45% -$176K 0.01% 860
2013
Q3
$443K Hold
10,200
0.02% 656
2013
Q2
$369K Buy
+10,200
New +$310K 0.02% 676

Other funds holding USNA

Barings's USNA Position: Q2 2018 in Review

Barings sold out of Usana Health Sciences (USNA) in Q2 2018, closing a stake of 11,800 shares — an estimated $1.01M sold.

Barings first reported a position in USNA in Q2 2013 and held it in 20 quarters. The position peaked at $1.01M in Q1 2018. 189 funds tracked by Wall St. Rank hold USNA as of Q2 2018.

  • Barings reported no remaining Usana Health Sciences position as of Q2 2018 after selling out during the quarter.
  • Barings sold 11,800 Usana Health Sciences shares in Q2 2018, an estimated $1.01M.
  • Barings first reported a position in Usana Health Sciences in Q2 2013 and held it in 20 quarters.
  • Barings's Usana Health Sciences position peaked at $1.01M in Q1 2018.
  • 189 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2018.

Based on Barings's 13F filing for Q2 2018, filed 3 Aug 2018.